(Yicai Global) Sept. 10 -- The World Health Organization has inducted one of Shanghai Fosun Pharmaceutical’s Covid-19 nucleic acid test kits onto its Emergency Use Listing, which will facilitate the use of the kit by the United Nations and other international organizations fighting Covid-19, the drugmaker said today.

The real-time polymerase chain reaction test kit, developed by unit Shanghai Fosun Long March Medical Science, is stable and highly automated, the Shanghai-based firm said on its WeChat account. It can assay 96 samples within two hours and is safe to use, it added.

The EUL procedure was set up in January to “expedite the availability of diagnostics in public health emergency situations around the world,” according to the WHO website. “It will help increase access to quality-assured, accurate tests for the disease,” it added.

Being on the list will hopefully promote the use of the kit in more nations including those in Africa, Fosun said.

This test kit has already been granted licenses by China's National Medical Products Administration, Australia's Therapeutic Goods Administration as well as the European Union. It has also been authorized for emergency use by the US Food and Drug Administration. The firm is exporting to over 10 overseas nations including France, Germany and Belgium, Fosun said.

Fosun Pharma [SHA:600196] closed down 0.62 percent on the mainland today at CNY48.41 (USD7), while its Hong Kong stock [HKG:2196] ended the day down marginally at HKD30.90 (USD4).